img_hblbg.jpg
logo.jpg
img_hbrbg.jpg
Home > Investors > Audited Financial Results
img_blueB.jpg

Investors

financials.jpg

img_blueB.jpg
img_inp_rblbg.jpg

Latest @ Ipca

Ipca - Ratlam formulations plant ranked third position in the National Energy Conservation Award - 2010.

img_inp_rblbg.jpg

Audited Financial Results

 (rupee. Crores)
Sr. No. Particulars Year Ended Consolidated Year Ended
    31-3-2015 31-3-2014 31-3-2015 31-3-2014
  PART I
1 Income from operations:
a) Net Sales/income from operations (Net of excise duty) 3059.91 3200.04 3116.60 3246.99
b) Other Operating Income 25.23 34.78 25.23 34.78
  Total Income from operations (net) 3085.14 3234.82 3141.83 3281.77
2 Expenses:
  a) Cost of materials consumed 1087.80 1097.51 1097.25 1102.81
  b) Purchases of stock-in-trade 123.12 90.49 125.34 95.13
  c) Changes in inventories of finished go work-in-progress and stock-in-trade (67.87) (60.63) (67.94) (61.36)
  d) Employee benefits expense 539.63 477.86 565.11 497.99
  e) Depreciation and amortisation expense 177.17 100.89 179.55 103.13
  f) Other expenses 881.96 824.36 892.98 836.64
  Total Expenses 2741.81 2530.48 2792.29 2574.34
3 Profit / (Loss) from operations before other Income, foreign exchange transactions/translations (gain)/loss, finance costs & exceptional items (1-2)

343.33

704.34

349.54 707.43
4 Other Income 35.77 21.43 35.76 22.26
5 Profit / (Loss) from ordinary activities before foreign exchange transactions/translations (gain)/loss, finance cost & exceptional items (3+4) 379.10 725.77 385.30 729.69
6 Foreign exchange transactions/translations (gain) / loss (4.25) 72.10 (4.17) 72.22
7 Finance costs 25.62 24.58 28.39 26.88
8 Profit from ordinary activities after foreign exchange transactions/translations (gain)/loss, finance cost but before exceptional items (5-6-7) 357.73 629.09 361.08 630.59
9 Exceptional item - - - -
10 Profit from ordinary activities before tax (8-9) 357.73 629.09 361.08 630.59
11 Tax Expense:
  Current - net of Short/(Excess) provision of earlier years 74.50 135.00 74.73 135.67
  Deferred 27.12 16.72 27.20 16.72
12 Net Profit from ordinary activities after tax (10-11) 256.11 477.37 259.15 478.20
13 Extraordinary items (net of tax expense) - - - -
14 Net Profit for the period (12- 13) 256.11 477.37 259.15 478.20
15 Share of (loss)/profits from Investments in Associates - - (4.92) (0.34)
16 Minority interest - - - -
17 Net Profit after taxes, minority interest and share of profit/(loss) of associates (14+15+16) 256.11 477.37 254.23 478.54
18 Paid-up equity share capital (Face value on rupee 2/- each) 25.24 25.24 25.24 25.24
19 Reserves excluding revaluation reserve 2208.09 1956.37 2183.19 1934.42
20 Earnings per share (rupee.)
  Basic 20.29 37.83 20.15 37.92
  Diluted 20.29 37.83 20.15 37.92
21 Debt service coverage ratio (DSCR) (No.of times)# 3.80 5.37 - -
22 Interest service coverage ratio (ISCR) (No. of times)## 19.19 26.89 - -
  PART II
A PARTICULARS OF SHAREHOLDING
1 Public shareholding
  - Number of shares 68280954 68280954 - -
  - Percentage of shareholding 54.11% 54.11% - -
2 Promoters and Promoter group shareholding
  a) Pledged / Encumbered
  - Number of shares 640350 1290350 - -
  - Percentage of Shares (as a % of the total shareholding of promoter and promoter group) 1.11% 2.23% - -
  - Percentage of Shares (as a % of the total share capital of the Company) 0.51% 1.02% - -
  b) Non-encumbered
  - Number of Shares 57277805 56627805 - -
  - Percentage of Shares (as a % of the total shareholding of promoter and promoter group) 98.89% 97.77% - -
  - Percentage of Shares (as a % of the total share capital of the company) 45.38% 44.87% - -
B NUMBER OF INVESTOR COMPLAINTS
  Pending at the beginning of the quarter - - - -
  Received during the quarter 54 66 - -
  Disposed of during the quarter 54 66 - -
  Remaining unresolved at the end of the quarter - - - -

# DSCR = [(Profit after tax before exceptional items + depreciation + interest on long term debts) / (Interest & Principal repayment of
long term debts during the period)]
## ISCR = [Profit before tax + depreciation + gross interest) / Gross interest]

Audited Statement of Assets and Liabilities as at 31st March, 2015

(rupee. Crores)

Sr. No. Particulars Standalone Consolidated
    31-3-2015 31-3-2014 31-3-2015 31-3-2014
A EQUITY AND LIABILITIES        
1 Shareholders' Funds        
  a) Capital 25.24 25.24 25.24 25.24
  b) Reservesand Surplus 2208.09 1956.37 2183.19 1934.42
  Sub-total - Shareholders' fund 2233.33 1981.61 2208.43 1959.66
2 Share Application money pending allotment - - - -
3 Minority Interest - - - -
4 Non-current liabilities        
  a) Long-term borrowings 501.40 292.12 503.21 294.00
  b) Deferred tax liabilities (net) 174.23 147.11 174.31 147.11
  c) Other Long-term liabilities 3.21 2.49 4.02 3.41
  d) Long-term provisions 17.66 14.49 18.03 14.93
  Sub-total - Non-current liabilities 696.50 456.21 699.57 459.45
5 Current liabilities        
  a) Short-term borrowings 320.98 137.96 325.35 143.94
  b) Trade payables 302.56 337.05 306.59 340.99
  c) Other current liabilities 234.93 249.82 236.44 250.88
  d) Short-term provisions 35.44 54.72 35.98 55.64
  Sub-total - Non-current liabilities 893.91 779.55 904.36 791.45
  TOTAL - EQUITY AND LIABILITIES 3823.74 3217.37 3812.36 3210.56
B ASSETS        
1 Non-current assets        
  a) Fixed assets 2019.91 1471.01 2033.21 1484.05
  b) Goodwill on consolidation - - 34.44 34.44
  c) Non-current investments 81.86 28.75 16.19 9.00
  d) Deferred tax assets (net) - - - -
  e) Long-term loans and advances 118.87 125.67 104.36 72.23
  f) Other non-current assets 10.04 9.30 10.18 9.42
  Sub-total - Non-current assets 2230.68 1634.73 2198.38 1609.14
2 Current assets        
  a) Current investments - 0.15 - 0.15
  b) Inventories 916.98 838.30 926.56 847.58
  c) Trade receivables 353.55 448.76 353.00 449.79
  d) Cash and cash equivalents 113.19 69.22 124.79 76.01
  e) Short-term loans and advances 46.84 64.56 47.46 66.36
  f) Other current assets 162.50 161.65 162.17 161.53
  Sub-total - current assets 1593.06 1582.64 1613.98 1601.42
  TOTAL - ASSETS 3823.74 3217.37 3812.36 3210.56

Notes:

  1. The above audited financial results, as reviewed by the Audit Committee, were approved and taken on record by the Board of Directors in their meeting held on May 30, 2015.
  2. The Board has recommended a final dividend of  rupee. 1/- per share of  rupee. 2/- each (50%) for the financial year 2014-15.
  3. In accordance with the provisions of Schedule II to the Companies Act 2013, effective from 1st April, 2014, the Company has revised the useful lives of its fixed assets. As a consequence of such revision, the charge for depreciation is higherthan the previously applied rates by  rupee. 21.85 crores fort he current quarter and  rupee. 50.94 crores for the year. For assets that have completed the useful lives as a consequence of the aforesaid revision, the carrying value as on 1st April, 2014 of  rupee. 13.26 crores had been charged to the opening balance of the surplus in statement of profit and loss in the first quarter along with the deferred tax effect thereon of  rupee. 4.51 crores. During the fourth quarter the Management following the MCA circular no. GSR 627(E) dated 29th August, 2014 has decided to charge the amount of  rupee. 13.26 crores as aforesaid to statement of profit & loss as against the earlier treatment of charging to the surplus in statement of profit & loss. The depreciation charge for the first quarter is accordingly higher by  rupee. 13.26 crores as compared to the depreciation disclosed in the first quarter. The depreciation for the current quarter includes  rupee. 13.26 crores as aforesaid.
  4. * The figures of the last quarter for the current year and for the previous year are the balancing figures between the audited figures in respect of the full financial year ended 31st March and unaudited published year-to-date figures up to the third quarter ended 31st December, which were subjected to limited review.
  5. In accordance with AS-17 "Segment Reporting", the Company has only one reportable primary business segment i.e. Pharmaceuticals, However, the Company has secondary geographical segment which is disclosed in Consolidated Financial Statements as per AS-17.
    Information about secondary geographical segments as per Consolidated Financial Statements:

    (rupee. Crores)

    Particulars India Outside India Total
      2014-15 2013-14 2014-15 2013-14 2014-15 2013-14
    Segment Revenue 1342.05 1186.28 1799.78 2095.49 3141.83 3281.77
    The segment asset and segment capital expenditure attributable to the segment "outside India" is less than 10% of the respective total asset and total capital expenditure and therefore not disclosed separately.
  6. Previous year figures have been regrouped and rearranged wherever necessary.

Place : Mumbai By Order of the Board
Date : May 30, 2014For Ipca Laboratories Limited

Premchand Godha
Chairman & Managing Director

Copyright © Ipca Laboratories Ltd. 2012. All Rights Reserved.